HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liyanage P Perera Selected Research

Liyanage P Perera Research Topics

Disease

7Neoplasms (Cancer)
01/2021 - 04/2008
7Vaccinia
04/2014 - 03/2003
5Tuberculosis (Tuberculoses)
01/2011 - 03/2009
4Infections
09/2013 - 04/2008
4Inflammation (Inflammations)
04/2013 - 09/2009
4Smallpox (Variola)
10/2010 - 01/2007
3Human Influenza (Influenza)
01/2022 - 04/2014
3Celiac Disease (Celiac Sprue)
01/2020 - 12/2011
3Pulmonary Tuberculosis
01/2011 - 07/2009
2Malaria
01/2015 - 01/2011
1Squamous Cell Carcinoma of Head and Neck
02/2020
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2020
1Ischemia
01/2019
1Hemorrhage
01/2019
1Papilledema
01/2019
1Pneumonia (Pneumonitis)
01/2019
1Uveitis
01/2019
1Autoimmune Lymphoproliferative Syndrome
10/2015
1Lymphadenopathy
10/2015
1Rheumatoid Arthritis
10/2015
1Renal Cell Carcinoma (Grawitz Tumor)
01/2015
1Melanoma (Melanoma, Malignant)
01/2015
1Inhalation anthrax
09/2013
1Enteropathy-Associated T-Cell Lymphoma
04/2013
1Capillary Leak Syndrome
05/2011
1Coinfection
01/2011
1Anthrax
10/2010
1Mpox (monkeypox)
10/2010
1Atrophy
09/2009
1Meningeal Tuberculosis (Tuberculous Meningitis)
03/2009
1Miliary Tuberculosis
03/2009
1Influenza in Birds (Avian Flu)
03/2009

Drug/Important Bio-Agent (IBA)

17Interleukin-15 (Interleukin 15)IBA
01/2020 - 03/2003
15VaccinesIBA
01/2018 - 03/2003
9CytokinesIBA
01/2018 - 03/2009
5AntigensIBA
09/2013 - 07/2009
3Proteins (Proteins, Gene)FDA Link
01/2015 - 07/2009
3Glutens (Glutelin)IBA
04/2013 - 09/2009
3Interleukin-2 (IL2)IBA
05/2011 - 03/2003
2Janus Kinase InhibitorsIBA
10/2015 - 04/2013
2tofacitinibIBA
10/2015 - 04/2013
2Influenza Vaccines (Influenza Vaccine)FDA Link
04/2014 - 03/2009
2Tuberculosis VaccinesIBA
01/2011 - 05/2010
2Smallpox Vaccine (Vaccine, Smallpox)FDA Link
10/2010 - 10/2010
2A-Form DNA (A-DNA)IBA
12/2009 - 07/2009
1Hemagglutinins (Hemagglutinin)IBA
01/2022
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2022
1Alemtuzumab (Campath)FDA Link
01/2021
1obinutuzumabIBA
01/2021
1avelumabIBA
01/2021
1mogamulizumabIBA
01/2021
1Monoclonal AntibodiesIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
02/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Pharmaceutical PreparationsIBA
01/2019
1Chemokine ReceptorsIBA
09/2017
1Chimeric Antigen ReceptorsIBA
09/2017
1Malaria VaccinesIBA
01/2015
1AntibodiesIBA
04/2014
1Anthrax Vaccines (Vaccines, Anthrax)IBA
09/2013
1HLA-DQ8 antigenIBA
04/2013
1Therapeutic UsesIBA
03/2012
1ElementsIBA
12/2011
1Mycobacterium tuberculosis antigensIBA
05/2010
1bis(p-chlorophenyl)acetic acid (DDA)IBA
12/2009
1BCG VaccineFDA Link
03/2009
1DryVax vaccineIBA
01/2007

Therapy/Procedure

2Therapeutics
10/2015 - 05/2011
1Immunomodulation
01/2019
1Intravenous Infusions
01/2019
1Immunotherapy
01/2015